Manuela Zucknick

Title: Manuela Zucknick: Innovator in Breast Cancer Diagnostics

Introduction

Manuela Zucknick is a prominent inventor based in Oslo, Norway. She has made significant contributions to the field of breast cancer diagnostics through her innovative research and inventions. Her work focuses on utilizing circulating microRNAs as biomarkers for diagnosing breast cancer, which has the potential to improve early detection and treatment outcomes.

Latest Patents

Manuela Zucknick holds a patent titled "Circulating miRNAs as markers for breast cancer." This invention is directed towards methods for diagnosing breast cancer, metastasizing breast cancer, or determining the circulating tumor cell (CTC) status in a subject. The methods involve determining the amount of at least one specific miRNA in a sample from a subject suspected of having breast cancer and comparing it with reference values to diagnose the condition. This innovative approach also includes devices and kits designed to facilitate these diagnostic methods.

Career Highlights

Manuela Zucknick is affiliated with Ruprecht-Karls-Universität Heidelberg, where she continues her research and development in the field of cancer diagnostics. Her work has garnered attention for its potential impact on patient care and treatment strategies.

Collaborations

Some of her notable coworkers include Barbara Burwinkel and Katarina Cuk, who contribute to the collaborative efforts in advancing cancer research and diagnostics.

Conclusion

Manuela Zucknick's contributions to breast cancer diagnostics through her innovative patent highlight her role as a leading inventor in the field. Her work not only enhances our understanding of cancer biomarkers but also paves the way for improved diagnostic methods that can benefit patients worldwide.